Glycosaminoglycans excretion in interstitial cystitis

被引：19

作者：

Akçay T. ^{[1
]}

Konukoǧlu D. ^{[1
]}

机构：

[1] Department of Biochemistry, Istanbul University, Cerrahpaşa Fac. of Medicine, Istanbul

来源：

International Urology and Nephrology | 1999年 / 31卷 / 4期

关键词：

Public Health; Healthy Subject; Glycosaminoglycan; Cystitis; Interstitial Cystitis;

D O I：

10.1023/A:1007198708404

中图分类号：

学科分类号：

摘要：

Glycosaminoglycans (GAGs) have been identified histochemically and biochemically in urothelium. They have been suggested to have an anti- adherence effect at the bladder surface important in the urothelial defence against bacterial and carcinogenic insult. The aim of this study was to investigate urinary GAGs excretion in patients with interstitial cystitis. Urinary GAG excretion was determined in patients with interstitial cystitis (n:34; 16 males, 18 females) and healthy subjects (n:34; 16 males, 18 females). Urinary GAG determinations were made by the dimethymethylene blue method. Student's t-test was used for statistical analysis of the results. Urinary GAG excretion was found to be elevated significantly in patients with interstitial cystitis (14.45±2.02 mg/g Cr) as compared to healthy subjects (10.11±2.3 mg/g Cr) (p<0.01). There was no significant difference in urinary GAG excretion between males and females in either the healthy subjects or in the patients. Determination of urinary GAG excretion may be an important non- invasive test in the investigation of patients with interstitial cystitis.

引用

页码：431 / 435

页数：4

共 17 条

[1]

Thorone I.D., Resnick M.I., A methodology for the characterisation of urinary glycosaminoglycans, J. Urol, 13, (1984)

[2]

Lilly L.D., Parson C.L., Bladder surface glycosaminoglycan is a human epithelial permeability barrier, Surg. Gynec., 171, (1990)

[3]

Hurst R.E., Parson C.L., Roy J.B., Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis, J. Urol., 149, (1993)

[4]

Gambaro G., Cicerello S., Mastrosimone G., Lawagnim T., Baggio B., High urinary excretion of glycosaminoglycans. A possible marker of glomerular involvement in diabetes, Metabolism, 38, (1989)

[5]

Nesse A., Garbossa G., Romero M.C., Bogado C.E., Zanchetta J.R., Glycosaminoglycans in urolithiasis, Nephron, 62, (1992)

[6]

Mitsuhaski H., Tsukada Y., Ono K., Yano S., Naruse T., Urine glycosaminoglycans and neparan sulphate excretions in adult patients with glomerular diseases, Clin. Nephrology, 39, (1993)

[7]

Konukoglu D., Akcay T., Erozenci A., The importance of urinary glycosaminoglycan as a marker for superficial bladder tumors, Cancer Biochem. Biophys, 15, (1995)

[8]

Parsons C.L., Schmidt J.D., Pollen J.J., Successful treatment of interstitial cystitis with sodium pentosanpolysulphate, J Urol., 130, (1983)

[9]

Gillenwater J.Y., Wein A.J., Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis, National Institute of Health, J. Urol., 140, (1988)

[10]

Pain G., Naia S., Dall'Amico R., Chandetti L., Zachello E.E., Catassi C., Simple spectrophotometric quantification of urinary excretion of glycosaminoglycan sulphates, Clin. Chem., 32, (1986)

← 1 2 →